- Lobbying
- willkie AND farr AND gallagher
Lobbying Arrangements Results for 'Willkie Farr Gallagher'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details |
ASSOCIATION OF DIRECTORY PUBLISHERS
|
WILLKIE FARR & GALLAGHER LLP | |||
Details Provide gudiance and counsel on climate change issues. |
Willkie Farr & Gallagher LLP
|
Barbour Griffith & Rogers, LLC d/b/a BGR Holding | |||
Details climate change |
Willkie Farr & Gallagher LLP
|
Downey McGrath Group, Inc. | |||
Details Market access issues |
Willkie Farr & Gallagher LLP
|
Thompson Hine LLP | |||
Details Section 301 trade actions. |
ARRIS U.S. Holdings, Inc.
|
WILLKIE FARR & GALLAGHER LLP | |||
Details S. 742, the "Ban Asbestos in America Act" (provisions related to a study of non-asbestiform minerals and elongated mineral particles). |
FEDERAL-MOGUL CORPORATION
|
WILLKIE FARR & GALLAGHER LLP | |||
Details Foreign regulation of U.S. suppliers of financial information services - CHINA: U.S. WTO case against China; implementation of U.S.-China Memorandum of Understanding (MOU) on licensing of foreign f... |
Bloomberg L.P.
|
WILLKIE FARR & GALLAGHER LLP | |||
Details Meeting at the request of USTR to respond to questions regarding NAFTA rules of origin. |
Mazda Motor of America, Inc. DBA Mazda North American Operations
|
WILLKIE FARR & GALLAGHER LLP | |||
Details The cumulative effect on the forest products industry of air emissions standards promulgated by the U.S. Environmental Protection Agency under the Clean Air Act. |
American Forest & Paper Association
|
WILLKIE FARR & GALLAGHER LLP | |||
Details Legislation affecting pharmaceutical patent litigation, including settlement of patent infringement claims (H.R. 1706 and S. 369). |
TEVA PHARMACEUTICALS USA., INC.
|
WILLKIE FARR & GALLAGHER LLP | |||
Details All terrain vehicle safety, implementation of the Consumer Product Safety Improvement Act ("CPSIA") (PL 110-314); possible amendments to the CPSIA. |
YAMAHA MOTOR CORPORATION, U.S.A.
|
WILLKIE FARR & GALLAGHER LLP | |||
Details Regulation of settlements of pharmaceutical patent litigation, including but not limited to S.316. |
TEVA PHARMACEUTICALS U.S.A., INC.
Pharmaceutical Manufacturing and Distribution |
WILLKIE FARR & GALLAGHER LLP | |||
Details Congressional approval of the Trans-Pacific Partnership ("TPP") Agreement. |
JAPAN AUTOMOBILE MANUFACTURERS ASSOCIATION
|
WILLKIE FARR & GALLAGHER LLP |